| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.25 | 7e-06 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |